Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1
Klaus Unsicker, Björn Spittau, Kerstin Krieglstein
Cytokine & Growth Factor Reviews (2013) Vol. 24, Iss. 4, pp. 373-384
Closed Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
Paul J. Emmerson, Feng Wang, Yong Du, et al.
Nature Medicine (2017) Vol. 23, Iss. 10, pp. 1215-1219
Closed Access | Times Cited: 542
GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
Satish Patel, Anna Álvarez-Guaita, Audrey Melvin, et al.
Cell Metabolism (2019) Vol. 29, Iss. 3, pp. 707-718.e8
Open Access | Times Cited: 384
GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2
Shan Li, Yanmin Ma, Peng‐Sheng Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 162
Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes
Maria Fasolino, Gregory W. Schwartz, Abhijeet R. Patil, et al.
Nature Metabolism (2022) Vol. 4, Iss. 2, pp. 284-299
Open Access | Times Cited: 104
Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders
Yasunori Fujita, Yu Taniguchi, Shoji Shinkai, et al.
Geriatrics and gerontology international/Geriatrics & gerontology international (2016) Vol. 16, Iss. S1, pp. 17-29
Open Access | Times Cited: 167
GDF15 and Growth Control
Paul J. Emmerson, Kevin L. Duffin, Sudhakar Chintharlapalli, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 145
GDF15 promotes EMT and metastasis in colorectal cancer
Chen Li, Jingyu Wang, Jianlu Kong, et al.
Oncotarget (2015) Vol. 7, Iss. 1, pp. 860-872
Open Access | Times Cited: 139
Single-nucleus transcriptomic survey of cell diversity and functional maturation in postnatal mammalian hearts
Peng Hu, Jian Liu, Juanjuan Zhao, et al.
Genes & Development (2018) Vol. 32, Iss. 19-20, pp. 1344-1357
Open Access | Times Cited: 130
Molecular liaisons between erythropoiesis and iron metabolism
Léon Kautz, Elizabeta Nemeth
Blood (2014) Vol. 124, Iss. 4, pp. 479-482
Open Access | Times Cited: 118
GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases
Yasunori Fujita, Masafumi Ito, Toshio Kojima, et al.
Mitochondrion (2014) Vol. 20, pp. 34-42
Closed Access | Times Cited: 118
Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets
Luc Rochette, Marianne Zeller, Yves Cottin, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 12, pp. 939-951
Open Access | Times Cited: 116
Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond
Shannon E. Mullican, Shamina M. Rangwala
Trends in Endocrinology and Metabolism (2018) Vol. 29, Iss. 8, pp. 560-570
Closed Access | Times Cited: 113
Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases
Thomas Mueller, Isabella Leitner, Margot Egger, et al.
Clinica Chimica Acta (2015) Vol. 445, pp. 155-160
Open Access | Times Cited: 106
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
Courtney Tuegel, Ronit Katz, Mariam Alam, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 4, pp. 519-528
Open Access | Times Cited: 102
Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs
Susannah Bloch, JEE-YAU LEE, Thomas Syburra, et al.
Thorax (2014) Vol. 70, Iss. 3, pp. 219-228
Open Access | Times Cited: 100
Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19
Peder L. Myhre, Christian Prebensen, Heidi Strand, et al.
Circulation (2020) Vol. 142, Iss. 22, pp. 2128-2137
Open Access | Times Cited: 99
GDF15 and Cardiac Cells: Current Concepts and New Insights
Luc Rochette, Geoffrey Dogon, Marianne Zeller, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8889-8889
Open Access | Times Cited: 97
Comprehensive Proteomics Analysis of Stressed Human Islets Identifies GDF15 as a Target for Type 1 Diabetes Intervention
Ernesto Nakayasu, Farooq Syed, Sarah A. Tersey, et al.
Cell Metabolism (2020) Vol. 31, Iss. 2, pp. 363-374.e6
Open Access | Times Cited: 93
Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer–Cardiovascular Cohort
Xue Bao, Yan Borné, Iram Faqir Muhammad, et al.
Diabetologia (2018) Vol. 62, Iss. 1, pp. 78-86
Open Access | Times Cited: 91
GDF-15 inhibits integrin activation and mouse neutrophil recruitment through the ALK-5/TGF-βRII heterodimer
Annette Artz, Stefan Butz, Dietmar Vestweber
Blood (2016) Vol. 128, Iss. 4, pp. 529-541
Open Access | Times Cited: 90
GDF 15 - A Novel Biomarker in the Offing for Heart Failure
Melvin George, Amrita Jena, Varsha Srivatsan, et al.
Current Cardiology Reviews (2016) Vol. 12, Iss. 1, pp. 37-46
Open Access | Times Cited: 88
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia
Jawed A. Siddiqui, Ramesh Pothuraju, Parvez Κhan, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 64, pp. 71-83
Open Access | Times Cited: 88
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angeliki M. Angelidi, Matthew J. Belanger, Alexander Kokkinos, et al.
Endocrine Reviews (2021) Vol. 43, Iss. 3, pp. 507-557
Open Access | Times Cited: 81
Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease
Juan Wang, Liqun Wei, Xinchun Yang, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 17
Open Access | Times Cited: 79
Activation of the hypothalamic–pituitary–adrenal axis by exogenous and endogenous GDF15
Irène Cimino, Hanna Kim, Y. C. Loraine Tung, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 27
Open Access | Times Cited: 71
Page 1 - Next Page

Scroll to top